I hesitate to say this because I'm not a medical person, I don't think I'm far off
the mark but what I say might need some polishing.......
In efti/keytruda trials efti encourages the immune system to release monocytes
that keytruda previously couldn't reach for treatment...Monocytes are a type
of white blood cells.....This is the basis of our combo trials with merck and keytruda
and if it can be proven that efti has a broad success rate with allowing keytruda access
to targeted cells it couldn't get at solo, guess what?...we're in the money.....
I hesitate to say this because I'm not a medical person, I don't...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.015(5.26%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.8¢ | 29.0¢ | $833.7K | 2.793M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 258479 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 221018 | 27 |
View Market Depth
| Last trade - 15.13pm 22/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |
